Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Sarin Exposures in A Cohort of British Military Participants in Human Experimental Research at Porton Down 1945-1987.

Keegan TJ, Carpenter LM, Brooks C, Langdon T, Venables KM.

Ann Work Expo Health. 2017 Dec 15;62(1):17-27. doi: 10.1093/annweh/wxx084.

PMID:
29136135
2.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.

3.

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

Tsang Y, Ciurlionis L, Kirby AM, Locke I, Venables K, Yarnold JR, Titley J, Bliss J, Coles CE; IMPORT Trial Management Group.

Br J Radiol. 2015;88(1056):20150453. doi: 10.1259/bjr.20150453. Epub 2015 Oct 22.

4.

Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Clark CH, Aird EG, Bolton S, Miles EA, Nisbet A, Snaith JA, Thomas RA, Venables K, Thwaites DI.

Br J Radiol. 2015;88(1055):20150251. doi: 10.1259/bjr.20150251. Epub 2015 Sep 2.

5.

A multi-institutional dosimetry audit of rotational intensity-modulated radiotherapy.

Clark CH, Hussein M, Tsang Y, Thomas R, Wilkinson D, Bass G, Snaith J, Gouldstone C, Bolton S, Nutbrown R, Venables K, Nisbet A.

Radiother Oncol. 2014 Nov;113(2):272-8. doi: 10.1016/j.radonc.2014.11.015. Epub 2014 Nov 23.

PMID:
25465734
6.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.

PMID:
24055415
7.

A UK pilot study: the specificity of the Word Memory Test effort sub-tests in acute minimal to mild head injury.

Hall VL, Worthington A, Venables K.

J Neuropsychol. 2014 Sep;8(2):216-30. doi: 10.1111/jnp.12021. Epub 2013 May 16.

PMID:
23679892
8.

Development of a novel treatment planning test for credentialing rotational intensity-modulated radiotherapy techniques in the UK.

Tsang Y, Ciurlionis L, Clark C, Venables K; NCRI Radiotherapy Trials Quality Assurance group.

Br J Radiol. 2013 Feb;86(1022):20120315. doi: 10.1259/bjr.20120315.

9.

Radiotherapy quality assurance: facilitation of radiotherapy research and implementation of technology.

Miles E, Venables K.

Clin Oncol (R Coll Radiol). 2012 Dec;24(10):710-2. doi: 10.1016/j.clon.2012.06.006. Epub 2012 Aug 1. No abstract available.

PMID:
22858426
10.

The impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapy.

Tsang Y, Haviland J, Venables K, Yarnold J; FAST Trial Management Group.

Radiother Oncol. 2012 Aug;104(2):143-7. Epub 2012 Jul 16.

PMID:
22809586
11.

Does participation in clinical trials influence the implementation of new techniques? A look at changing techniques in breast radiotherapy in the UK.

Venables K, Tsang Y, Ciurlionis L, Coles CE, Yarnold JR.

Clin Oncol (R Coll Radiol). 2012 Oct;24(8):e100-5. doi: 10.1016/j.clon.2012.06.010. Epub 2012 Jul 12.

PMID:
22795830
12.

Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.

Tsang Y, Venables K, Yarnold J; FAST Trial Management Group.

Br J Radiol. 2012 Sep;85(1017):e647-53. Epub 2012 Jan 31.

13.

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

FAST Trialists group, Agrawal RK, Alhasso A, Barrett-Lee PJ, Bliss JM, Bliss P, Bloomfield D, Bowen J, Brunt AM, Donovan E, Emson M, Goodman A, Harnett A, Haviland JS, Kaggwa R, Morden JP, Robinson A, Simmons S, Stewart A, Sydenham MA, Syndikus I, Tremlett J, Tsang Y, Wheatley D, Venables K, Yarnold JR.

Radiother Oncol. 2011 Jul;100(1):93-100. doi: 10.1016/j.radonc.2011.06.026.

PMID:
21752481
14.

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR; START Trial Management Group.

Lancet Oncol. 2010 Mar;11(3):231-40. doi: 10.1016/S1470-2045(09)70382-1. Epub 2010 Feb 6.

15.

Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study.

Carpenter LM, Linsell L, Brooks C, Keegan TJ, Langdon T, Doyle P, Maconochie NE, Fletcher T, Nieuwenhuijsen MJ, Beral V, Venables KM.

BMJ. 2009 Mar 24;338:b655. doi: 10.1136/bmj.b655.

16.

Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study.

Venables KM, Brooks C, Linsell L, Keegan TJ, Langdon T, Fletcher T, Nieuwenhuijsen MJ, Maconochie NE, Doyle P, Beral V, Carpenter LM.

BMJ. 2009 Mar 24;338:b613. doi: 10.1136/bmj.b613.

17.

Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa.

Miles EA, Venables K, Hoskin PJ, Aird EG; START Trial Management Group.

Radiother Oncol. 2009 Apr;91(1):42-8. doi: 10.1016/j.radonc.2008.11.016. Epub 2009 Feb 3.

PMID:
19195731
18.

Exposures recorded for participants in the UK Chemical Warfare Agent Human Research Programme, 1941-1989.

Keegan TJ, Walker SA, Brooks C, Langdon T, Linsell L, Maconochie NE, Doyle P, Fletcher T, Nieuwenhuijsen MJ, Carpenter LM, Venables KM.

Ann Occup Hyg. 2009 Jan;53(1):83-97. doi: 10.1093/annhyg/men040.

PMID:
19131404
19.

Quality of occupational health provision: two rating scales and their determinants.

Venables KM, Allender S.

Occup Med (Lond). 2008 Sep;58(6):439-42. doi: 10.1093/occmed/kqn076. Epub 2008 Jun 18.

PMID:
18562545
20.

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR.

Lancet Oncol. 2008 Apr;9(4):331-41. doi: 10.1016/S1470-2045(08)70077-9. Epub 2008 Mar 19.

Supplemental Content

Loading ...
Support Center